Extending the structure−activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors

Chao Yang, Iris L.K. Wong, Kai Peng, Zhen Liu, Peng Wang, Tingfu Jiang, Tao Jiang, Ming Cheung Chow, Sheng Biao Wan

Research output: Journal article publicationJournal articleAcademic researchpeer-review

10 Citations (Scopus)


Preliminary structure-activity study shows that A ring and its two methoxy groups are important pharmacophores for P-gp inhibiting activity. Among all derivatives, 23 is the most potent P-gp modulator with EC50of 120–165 nM in reversing paclitaxel, DOX, vinblastine and vincristine resistance. It is relatively safe to use with selective index at least greater than 606 compared to verapamil. Mechanistic study demonstrates that compound 23 reverses P-gp mediated drug resistance by inhibiting transport activity of P-gp, thereby restoring intracellular drug accumulation. In summary, our study demonstrates that ningalin B analogue 23 is a non-cytotoxic and effective P-gp chemosensitizer that can be used in the future for reversing P-gp mediated clinical cancer drug resistance.
Original languageEnglish
Pages (from-to)795-806
Number of pages12
JournalEuropean Journal of Medicinal Chemistry
Publication statusPublished - 1 Jan 2017


  • ATP-Binding cassette (ABC) transporter
  • Multidrug resistance (MDR)
  • Ningalin B
  • P-glycoprotein (P-gp)
  • P-gp chemosensitizer

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this